Sterling Capital Management LLC lifted its position in CVS Health Corp (NYSE:CVS) by 17.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,621,394 shares of the pharmacy operator’s stock after acquiring an additional 242,930 shares during the quarter. CVS Health makes up approximately 1.0% of Sterling Capital Management LLC’s portfolio, making the stock its 19th largest position. Sterling Capital Management LLC’s holdings in CVS Health were worth $104,337,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CVS. Camarda Financial Advisors LLC purchased a new position in shares of CVS Health in the 2nd quarter worth about $102,000. Quantbot Technologies LP purchased a new position in shares of CVS Health in the 1st quarter worth about $103,000. Kiley Juergens Wealth Management LLC purchased a new position in shares of CVS Health in the 2nd quarter worth about $103,000. Legacy Advisors LLC boosted its holdings in shares of CVS Health by 7,100.0% in the 2nd quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock worth $116,000 after buying an additional 1,775 shares during the last quarter. Finally, Squar Milner Financial Services LLC purchased a new position in shares of CVS Health in the 2nd quarter worth about $122,000. Hedge funds and other institutional investors own 83.57% of the company’s stock.

In other CVS Health news, EVP Kevin Hourican sold 8,564 shares of the company’s stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $75.00, for a total transaction of $642,300.00. Following the sale, the executive vice president now directly owns 12,135 shares of the company’s stock, valued at $910,125. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.53% of the stock is owned by corporate insiders.

A number of equities analysts recently weighed in on CVS shares. Mizuho reissued a “buy” rating on shares of CVS Health in a report on Saturday, June 30th. ValuEngine raised shares of CVS Health from a “strong sell” rating to a “sell” rating in a report on Tuesday, August 28th. Royal Bank of Canada reissued a “buy” rating and issued a $90.00 price target on shares of CVS Health in a report on Wednesday, August 8th. Morgan Stanley cut their price target on shares of CVS Health from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Tuesday, July 3rd. Finally, Citigroup reaffirmed a “buy” rating and set a $81.00 price objective on shares of CVS Health in a report on Monday, July 9th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the stock. CVS Health presently has a consensus rating of “Buy” and a consensus price target of $86.04.

NYSE CVS opened at $76.91 on Friday. The stock has a market cap of $78.72 billion, a price-to-earnings ratio of 13.04, a price-to-earnings-growth ratio of 1.04 and a beta of 1.01. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $84.00. The company has a current ratio of 2.34, a quick ratio of 1.87 and a debt-to-equity ratio of 1.73.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.61 by $0.08. The business had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The company’s revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.33 earnings per share. analysts anticipate that CVS Health Corp will post 7.05 earnings per share for the current fiscal year.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Featured Story: What are Closed-End Mutual Funds?

Want to see what other hedge funds are holding CVS? Visit to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with's FREE daily email newsletter.